We examined the current literature to understand factors that influence endocrine therapy
(ET) adherence among racial/ethnic and socioeconomic subpopulations of breast cancer …

Purpose Adherence to endocrine therapy for hormone positive breast cancer is a significant
problem, especially in minority populations. Further, endocrine therapy reduces recurrence …

Background Differential use of endocrine therapy (ET) by race may contribute to breast
cancer outcome disparities, but racial differences in ET behaviors are poorly understood …

Importance Though adjuvant endocrine therapy (AET) has proven efficacy in treating
hormone receptor–positive (HR-positive) breast cancer, patient adherence to AET and …

Importance Few new treatments tested in phase 3 cancer randomized clinical trials show an
overall survival benefit. Although understanding whether the benefits are consistent among …

Background Early discontinuation is a substantial barrier to the delivery of endocrine
therapies (ETs) and may influence recurrence and survival. The authors investigated the …

Background For women with hormone receptor positive breast cancer, long‐term endocrine
therapy (ET) can greatly reduce the risk of recurrence, yet adherence is low‐particularly …

Objectives To provide a brief overview of disparities across the spectrum of breast cancer
incidence, treatment, and long-term care during the survivorship period. Data Sources …

The disparity in outcomes of breast cancer for Black compared with White women in the US
is well known and persistent over time, with the largest disparities appearing among women …

Introduction Many women in rural Ethiopia do not receive adjuvant therapy following breast
cancer surgery despite the majority being diagnosed with estrogen-receptor-positive breast …